International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

Abstract Background Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting)...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
格式: Artigo
語言:Inglês
出版: BMC 2019-04-01
叢編:Thrombosis Journal
主題:
Anticoagulant
Antithrombotic
Atrial fibrillation
Outcomes
Registry
Rivaroxaban
在線閱讀:http://link.springer.com/article/10.1186/s12959-019-0195-7
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍